[1]Patent:US2004/167142,2004,A1.Locationinpatent:Page/Pagecolumn8;9
[2]Patent:WO2019/104011,2019,A1.Locationinpatent:Paragraph00293-00294;00296
5748-41-4
109524-03-0
1762-83-0
885962-82-3
19482-11-2
773872-39-2
244022-67-1 | 2,4-Dibromo-6-fluorophenyl isothiocyanate | AA00BDNT | MFCD00832697
24139-17-1 | 5-Chloro-3-phenyl-1H-indole-2-carbonitrile | AA00BDTT | MFCD00974247
225217-42-5 | 4-Methylumbelliferyl2-O-(a-L-fucopyranosyl)-b-D-galactopyranoside | AA00BE1K | MFCD01863429
266359-83-5 | Repertaxin | AA00BE89 | MFCD18633292
227202-21-3 | 6-fluoro-4-oxochromene-3-carbonitrile | AA00BEB8 | MFCD03094001
203784-52-5 | Nortriptyline-d3 Hydrochloride | AA00BEHY | MFCD00198172
27906-91-8 | (2-phenylethyl)propylamine | AA00BEQI | MFCD03724002
211513-37-0 | Dalcetrapib | AA00BF09 | MFCD06407886
223488-57-1 | Evatanepag | AA00BF4O | MFCD09833940
300697-12-5 | N2-Phenyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine | AA00BF9Z | MFCD04618164